PLoS ONE, ISSN 1932-6203, 05/2014, Volume 9, Issue 5, p. e96810
Background: Poor-quality life-saving medicines are a major public health threat, particularly in settings with a weak regulatory environment. Insufficient...
COUNTERFEIT | SOUTHEAST-ASIA | PHARMACOKINETICS | PYRIMETHAMINE | MALARIA CASE-MANAGEMENT | MULTIDISCIPLINARY SCIENCES | HPLC METHOD | MEDICINES | PRIMAQUINE | SUBSTANDARD | ANTI-MALARIALS | Papua New Guinea | Humans | Amodiaquine - analysis | Artemisinins - standards | Antimalarials - standards | Antimalarials - analysis | Quinine - therapeutic use | Primaquine - analysis | Chloroquine - standards | Amodiaquine - therapeutic use | Drug Resistance | Quality Control | Malaria, Falciparum - drug therapy | Biosimilar Pharmaceuticals - therapeutic use | Biosimilar Pharmaceuticals - standards | Quinine - analysis | Amoxicillin - standards | Chloroquine - therapeutic use | Antimalarials - therapeutic use | Chloroquine - analysis | Quinine - standards | Artemisinins - analysis | Artemisinins - therapeutic use | Health Facilities | Malaria, Vivax - drug therapy | Primaquine - therapeutic use | Amoxicillin - therapeutic use | Amoxicillin - analysis | Amodiaquine - standards | Biosimilar Pharmaceuticals - analysis | Primaquine - standards | Surveys | Plasmodium falciparum | Health facilities | Antibiotics | Malaria | Primaquine | Amoxicillin | Liquid chromatography | Drug resistance | Health aspects | Logistics | Drugs | Laboratories | Supply chains | Artemisinin | Licenses | Quality | Drug dosages | Public health | Vector-borne diseases | Procurement | Medical research | Health risks | Pyrimethamine | Health centres | Pharmacology | High-performance liquid chromatography | Quinine | Counterfeiting | Hospital facilities | Storage conditions | Pharmacy | Quality control | Regulatory mechanisms (biology) | Amodiaquine | Artemether | Warehouses | Drug stores | High performance liquid chromatography | Pharmaceuticals
COUNTERFEIT | SOUTHEAST-ASIA | PHARMACOKINETICS | PYRIMETHAMINE | MALARIA CASE-MANAGEMENT | MULTIDISCIPLINARY SCIENCES | HPLC METHOD | MEDICINES | PRIMAQUINE | SUBSTANDARD | ANTI-MALARIALS | Papua New Guinea | Humans | Amodiaquine - analysis | Artemisinins - standards | Antimalarials - standards | Antimalarials - analysis | Quinine - therapeutic use | Primaquine - analysis | Chloroquine - standards | Amodiaquine - therapeutic use | Drug Resistance | Quality Control | Malaria, Falciparum - drug therapy | Biosimilar Pharmaceuticals - therapeutic use | Biosimilar Pharmaceuticals - standards | Quinine - analysis | Amoxicillin - standards | Chloroquine - therapeutic use | Antimalarials - therapeutic use | Chloroquine - analysis | Quinine - standards | Artemisinins - analysis | Artemisinins - therapeutic use | Health Facilities | Malaria, Vivax - drug therapy | Primaquine - therapeutic use | Amoxicillin - therapeutic use | Amoxicillin - analysis | Amodiaquine - standards | Biosimilar Pharmaceuticals - analysis | Primaquine - standards | Surveys | Plasmodium falciparum | Health facilities | Antibiotics | Malaria | Primaquine | Amoxicillin | Liquid chromatography | Drug resistance | Health aspects | Logistics | Drugs | Laboratories | Supply chains | Artemisinin | Licenses | Quality | Drug dosages | Public health | Vector-borne diseases | Procurement | Medical research | Health risks | Pyrimethamine | Health centres | Pharmacology | High-performance liquid chromatography | Quinine | Counterfeiting | Hospital facilities | Storage conditions | Pharmacy | Quality control | Regulatory mechanisms (biology) | Amodiaquine | Artemether | Warehouses | Drug stores | High performance liquid chromatography | Pharmaceuticals
Journal Article
Tropical Medicine & International Health, ISSN 1360-2276, 12/2004, Volume 9, Issue 12, pp. 1241 - 1246
Summary Objective To assess the prevalence of counterfeit antimalarial drugs in Southeast (SE) Asia. Design Cross‐sectional survey. Setting Pharmacies and...
Southeast Asia | malaria | fake antimalarials | counterfeit drugs | Counterfeit drugs | Fake antimalarials | Malaria | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | DRUGS | ARTESUNATE | TROPICAL MEDICINE | Mefloquine - standards | Cross-Sectional Studies | Humans | Artemisinins - standards | Antimalarials - standards | Drug Labeling - standards | Asia, Southeastern | Malaria - prevention & control | Self Medication - standards | Artemisinins - analysis | Sesquiterpenes - analysis | Antimalarials - chemistry | Mefloquine - analysis | Sesquiterpenes - standards | Fraud - statistics & numerical data | Antimalarials - supply & distribution
Southeast Asia | malaria | fake antimalarials | counterfeit drugs | Counterfeit drugs | Fake antimalarials | Malaria | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | DRUGS | ARTESUNATE | TROPICAL MEDICINE | Mefloquine - standards | Cross-Sectional Studies | Humans | Artemisinins - standards | Antimalarials - standards | Drug Labeling - standards | Asia, Southeastern | Malaria - prevention & control | Self Medication - standards | Artemisinins - analysis | Sesquiterpenes - analysis | Antimalarials - chemistry | Mefloquine - analysis | Sesquiterpenes - standards | Fraud - statistics & numerical data | Antimalarials - supply & distribution
Journal Article
Malaria Journal, ISSN 1475-2875, 05/2017, Volume 16, Issue 1, pp. 204 - 21
Background: Quality of artemisinin-based combination therapy (ACT) is important for ensuring malaria parasite clearance and protecting the efficacy of...
ACT | Regulation | Anti-malarial | Medicine quality | INFECTIOUS DISEASES | PRICE | SUB-SAHARAN AFRICA | PRIVATE-SECTOR | ANTIMALARIAL MEDICINES | PLASMODIUM-FALCIPARUM MALARIA | TROPICAL MEDICINE | DRUG QUALITY | SUBSIDY | RESISTANCE | KENYA | WORLD | PARASITOLOGY | Africa South of the Sahara | Public Sector - economics | Artemisinins - standards | Antimalarials - standards | Drug Therapy, Combination | Private Sector - economics | Drugs | Therapy | Market entry | Products | Endemic species | Importation | Countries | Consumers | Artemisinin | Public sector | Regulatory approval | Control | Quality | Subsidies | Manufacturing | Trends | Safety | Pharmaceutical industry | Private sector | Protection | Public health | Dihydroartemisinin | Vector-borne diseases | Availability | Human diseases | Malaria | Urban areas | Good Manufacturing Practice | Market penetration | Standards | Medicine | Studies | Surveys | Descriptive labeling | Spreading | Distribution | Artemether | Health and safety
ACT | Regulation | Anti-malarial | Medicine quality | INFECTIOUS DISEASES | PRICE | SUB-SAHARAN AFRICA | PRIVATE-SECTOR | ANTIMALARIAL MEDICINES | PLASMODIUM-FALCIPARUM MALARIA | TROPICAL MEDICINE | DRUG QUALITY | SUBSIDY | RESISTANCE | KENYA | WORLD | PARASITOLOGY | Africa South of the Sahara | Public Sector - economics | Artemisinins - standards | Antimalarials - standards | Drug Therapy, Combination | Private Sector - economics | Drugs | Therapy | Market entry | Products | Endemic species | Importation | Countries | Consumers | Artemisinin | Public sector | Regulatory approval | Control | Quality | Subsidies | Manufacturing | Trends | Safety | Pharmaceutical industry | Private sector | Protection | Public health | Dihydroartemisinin | Vector-borne diseases | Availability | Human diseases | Malaria | Urban areas | Good Manufacturing Practice | Market penetration | Standards | Medicine | Studies | Surveys | Descriptive labeling | Spreading | Distribution | Artemether | Health and safety
Journal Article
BMJ, ISSN 0959-8138, 02/2007, Volume 334, Issue 7590, pp. 403 - 406
Objective To compare rapid diagnostic tests (RDTs) for malaria with routine microscopy in guiding treatment decisions for febrile patients.Design Randomised...
Disease transmission | Malaria | Microscopy | Antibiotics | Artemisinins | Antimalarials | Research | Drug prescriptions | Medical diagnostic tests | Diseases | Age groups | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | BACTEREMIA | ADULTS | ENDEMIC AREA | PREVALENCE | CLINICAL ALGORITHMS | KENYA | CHILDREN | FEVER | Fever - parasitology | Malaria, Falciparum - drug therapy | Reagent Strips - standards | Point-of-Care Systems - standards | Humans | Tanzania | Male | Antimalarials - therapeutic use | Anti-Bacterial Agents - therapeutic use | Malaria, Falciparum - diagnosis | Female | Child | Microscopy - standards | Parasitology - standards
Disease transmission | Malaria | Microscopy | Antibiotics | Artemisinins | Antimalarials | Research | Drug prescriptions | Medical diagnostic tests | Diseases | Age groups | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | BACTEREMIA | ADULTS | ENDEMIC AREA | PREVALENCE | CLINICAL ALGORITHMS | KENYA | CHILDREN | FEVER | Fever - parasitology | Malaria, Falciparum - drug therapy | Reagent Strips - standards | Point-of-Care Systems - standards | Humans | Tanzania | Male | Antimalarials - therapeutic use | Anti-Bacterial Agents - therapeutic use | Malaria, Falciparum - diagnosis | Female | Child | Microscopy - standards | Parasitology - standards
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2012, Volume 12, Issue 6, pp. 488 - 496
Summary Poor-quality antimalarial drugs lead to drug resistance and inadequate treatment, which pose an urgent threat to vulnerable populations and jeopardise...
Infectious Disease | COUNTERFEIT | INFECTIOUS DISEASES | FAKE ARTESUNATE | TABLETS SOLD | ARTEMISININ RESISTANCE | PYRIMETHAMINE | PLASMODIUM-FALCIPARUM | AMODIAQUINE | PHARMACIES | MALARIA | MEDICINES | Asia, Southeastern | Humans | Antimalarials - chemistry | Africa South of the Sahara | Antimalarials - standards | Counterfeit Drugs | Drug Labeling - standards | Drug Packaging - standards | Drugs | Antimalarials | Malaria | Drug resistance | Analysis
Infectious Disease | COUNTERFEIT | INFECTIOUS DISEASES | FAKE ARTESUNATE | TABLETS SOLD | ARTEMISININ RESISTANCE | PYRIMETHAMINE | PLASMODIUM-FALCIPARUM | AMODIAQUINE | PHARMACIES | MALARIA | MEDICINES | Asia, Southeastern | Humans | Antimalarials - chemistry | Africa South of the Sahara | Antimalarials - standards | Counterfeit Drugs | Drug Labeling - standards | Drug Packaging - standards | Drugs | Antimalarials | Malaria | Drug resistance | Analysis
Journal Article
Expert Review of Anti-infective Therapy, ISSN 1478-7210, 06/2016, Volume 14, Issue 6, pp. 531 - 533
Resistance | antimalarials | medicine quality | malaria | falciparum | MEDICINES | CHLOROQUINE RESISTANCE | ANTI-MALARIALS | AFRICA | LAO PDR | PLASMODIUM-FALCIPARUM | PHARMACOLOGY & PHARMACY | SPREAD | ARTESUNATE | Pyrimethamine - therapeutic use | Malaria, Falciparum - drug therapy | Pyrimethamine - standards | Humans | Chloroquine - therapeutic use | Antimalarials - therapeutic use | Artemisinins - standards | Antimalarials - standards | Drug Resistance, Microbial | Plasmodium falciparum | Artemisinins - therapeutic use | Sulfadoxine - therapeutic use | Chloroquine - standards | Sulfadoxine - standards | Drug Therapy, Combination | Drug Combinations
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2017, Volume 12, Issue 12, p. e0189758
Background Private sector drug shops are an important source of malaria treatment in Africa, yet diagnosis without parasitological testing is common among...
HEALTH FACILITIES | TREATING UNCOMPLICATED MALARIA | COMBINATION THERAPY | MULTIDISCIPLINARY SCIENCES | RETAILERS | CAMEROON | EFFECTIVENESS ACCEPTABILITY CURVES | Fever - parasitology | Drug Evaluation, Preclinical - standards | Humans | Fever - diagnosis | Antimalarials - therapeutic use | Artemisinins - standards | Antimalarials - standards | Artemisinins - therapeutic use | Malaria - epidemiology | Private Sector - standards | Cost-Benefit Analysis | Diagnostic Tests, Routine - methods | Malaria - parasitology | Uganda | Malaria - drug therapy | Fever - drug therapy | Commerce - standards | Usage | Malaria | Economic aspects | Medical tests | Diagnosis | Research | Cost benefit analysis | Intervention | Drugs | Costs | Diagnostic tests | Artemisinin | Training | Prices | Randomization | Subsidies | Private sector | Public health | Vector-borne diseases | Sensitivity analysis | Households | Health care policy | Medical screening | Disease control | Fever | Studies | Prescription drugs | Microscopy | Customers | Diagnostic systems | Cost analysis | Monte Carlo simulation | Hygiene
HEALTH FACILITIES | TREATING UNCOMPLICATED MALARIA | COMBINATION THERAPY | MULTIDISCIPLINARY SCIENCES | RETAILERS | CAMEROON | EFFECTIVENESS ACCEPTABILITY CURVES | Fever - parasitology | Drug Evaluation, Preclinical - standards | Humans | Fever - diagnosis | Antimalarials - therapeutic use | Artemisinins - standards | Antimalarials - standards | Artemisinins - therapeutic use | Malaria - epidemiology | Private Sector - standards | Cost-Benefit Analysis | Diagnostic Tests, Routine - methods | Malaria - parasitology | Uganda | Malaria - drug therapy | Fever - drug therapy | Commerce - standards | Usage | Malaria | Economic aspects | Medical tests | Diagnosis | Research | Cost benefit analysis | Intervention | Drugs | Costs | Diagnostic tests | Artemisinin | Training | Prices | Randomization | Subsidies | Private sector | Public health | Vector-borne diseases | Sensitivity analysis | Households | Health care policy | Medical screening | Disease control | Fever | Studies | Prescription drugs | Microscopy | Customers | Diagnostic systems | Cost analysis | Monte Carlo simulation | Hygiene
Journal Article
Lancet, The, ISSN 0140-6736, 2012, Volume 380, Issue 9857, pp. 1916 - 1926
Summary Background Malaria is one of the greatest causes of mortality worldwide. Use of the most effective treatments for malaria remains inadequate for those...
Internal Medicine | MEDICINE, GENERAL & INTERNAL | GLOBAL SUBSIDY | ACT | TANZANIA | Drug Costs | Malaria - economics | Humans | Africa | Lactones - standards | Public Sector - economics | Artemisinins - standards | Antimalarials - standards | Artemisinins - supply & distribution | Pilot Projects | Pharmacies - statistics & numerical data | Private Sector - economics | Antimalarials - economics | Malaria - drug therapy | Pharmacies - economics | Artemisinins - economics | Lactones - economics | Lactones - supply & distribution | Marketing of Health Services | Antimalarials - supply & distribution | Complications and side effects | Malaria | Antimalarials | Economic aspects | Dosage and administration | Research | Drug therapy | Drugs | Prices | Mortality | Profits | Subsidies | Public health | Polls & surveys | Market shares | Public sector
Internal Medicine | MEDICINE, GENERAL & INTERNAL | GLOBAL SUBSIDY | ACT | TANZANIA | Drug Costs | Malaria - economics | Humans | Africa | Lactones - standards | Public Sector - economics | Artemisinins - standards | Antimalarials - standards | Artemisinins - supply & distribution | Pilot Projects | Pharmacies - statistics & numerical data | Private Sector - economics | Antimalarials - economics | Malaria - drug therapy | Pharmacies - economics | Artemisinins - economics | Lactones - economics | Lactones - supply & distribution | Marketing of Health Services | Antimalarials - supply & distribution | Complications and side effects | Malaria | Antimalarials | Economic aspects | Dosage and administration | Research | Drug therapy | Drugs | Prices | Mortality | Profits | Subsidies | Public health | Polls & surveys | Market shares | Public sector
Journal Article
BMC Pharmacology and Toxicology, ISSN 2050-6511, 10/2016, Volume 17, Issue 1, p. 48
Background: Ghana changed their antimalarial drug policy from monotherapies to Artemisinin-based Combination Therapies in 2004 in order to provide more...
Malaria | Artemisinin-based combinations | Mortality | Ghana | Counterfeit medicines | Falsified medicines | Morbidity | Substandard medicines | BEHAVIOR | MEDICINES | ANTIMALARIALS | AFRICA | SOUTHEAST-ASIA | DRUGS | PHARMACOLOGY & PHARMACY | TOXICOLOGY | EPIDEMIOLOGY | Health Care Sector - standards | Cross-Sectional Studies | Humans | Artemisinins - administration & dosage | Anti-Infective Agents - standards | Artemisinins - standards | Antimalarials - standards | Public Health - methods | Ghana - epidemiology | Anti-Infective Agents - administration & dosage | Antimalarials - administration & dosage | Malaria - epidemiology | Malaria - drug therapy | Public Health - standards | Drug Therapy, Combination - standards | Antimalarials | Complications and side effects | Dosage and administration | Research | Drug therapy
Malaria | Artemisinin-based combinations | Mortality | Ghana | Counterfeit medicines | Falsified medicines | Morbidity | Substandard medicines | BEHAVIOR | MEDICINES | ANTIMALARIALS | AFRICA | SOUTHEAST-ASIA | DRUGS | PHARMACOLOGY & PHARMACY | TOXICOLOGY | EPIDEMIOLOGY | Health Care Sector - standards | Cross-Sectional Studies | Humans | Artemisinins - administration & dosage | Anti-Infective Agents - standards | Artemisinins - standards | Antimalarials - standards | Public Health - methods | Ghana - epidemiology | Anti-Infective Agents - administration & dosage | Antimalarials - administration & dosage | Malaria - epidemiology | Malaria - drug therapy | Public Health - standards | Drug Therapy, Combination - standards | Antimalarials | Complications and side effects | Dosage and administration | Research | Drug therapy
Journal Article
Transactions of The Royal Society of Tropical Medicine and Hygiene, ISSN 0035-9203, 02/2017, Volume 111, Issue 2, pp. 90 - 96
Abstract Background Artemisinin combination therapy is first-line therapy for treatment of malaria, which is one of the most significant public health problems...
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | Malaria | PLASMODIUM-FALCIPARUM | Artemisinin | RESISTANCE | Lumefantrine | Nigeria | ARTESUNATE | TROPICAL MEDICINE | Malaria, Falciparum - drug therapy | Ethanolamines - standards | Fluorenes - analysis | Humans | Drug Evaluation | Fluorenes - standards | Artemisinins - standards | Antimalarials - standards | Ethanolamines - chemistry | Ethanolamines - analysis | Antimalarials - analysis | Artemisinins - analysis | Fluorenes - chemistry | Antimalarials - chemistry | Drug and Narcotic Control | Artemisinins - chemistry | Drug Combinations | Quality Control
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | Malaria | PLASMODIUM-FALCIPARUM | Artemisinin | RESISTANCE | Lumefantrine | Nigeria | ARTESUNATE | TROPICAL MEDICINE | Malaria, Falciparum - drug therapy | Ethanolamines - standards | Fluorenes - analysis | Humans | Drug Evaluation | Fluorenes - standards | Artemisinins - standards | Antimalarials - standards | Ethanolamines - chemistry | Ethanolamines - analysis | Antimalarials - analysis | Artemisinins - analysis | Fluorenes - chemistry | Antimalarials - chemistry | Drug and Narcotic Control | Artemisinins - chemistry | Drug Combinations | Quality Control
Journal Article
Malaria Journal, ISSN 1475-2875, 2010, Volume 9, Issue 1, pp. 298 - 298
Background: Maintaining adequate supplies of anti-malarial medicines at the health facility level in rural subSaharan Africa is a major barrier to effective...
INFECTIOUS DISEASES | MALARIA | PARASITOLOGY | TROPICAL MEDICINE | Drug Storage - methods | Humans | Tanzania | Telecommunications | Artemisinins - supply & distribution | Health Facility Administration | Fluorenes - supply & distribution | Quinine - supply & distribution | Rural Population | Ethanolamines - supply & distribution | Malaria - drug therapy | Antimalarials - supply & distribution | Drug Combinations | Supply and demand | Malaria | Demographic aspects | Antimalarials | Research | Drug therapy | Health aspects | Drugs | Health facilities | Composition | Stocks | Rural areas | Mapping | Management | Quinine | Institutions | Medicine | Technology | Cellular telephones | Weekly | Artemether | Visibility
INFECTIOUS DISEASES | MALARIA | PARASITOLOGY | TROPICAL MEDICINE | Drug Storage - methods | Humans | Tanzania | Telecommunications | Artemisinins - supply & distribution | Health Facility Administration | Fluorenes - supply & distribution | Quinine - supply & distribution | Rural Population | Ethanolamines - supply & distribution | Malaria - drug therapy | Antimalarials - supply & distribution | Drug Combinations | Supply and demand | Malaria | Demographic aspects | Antimalarials | Research | Drug therapy | Health aspects | Drugs | Health facilities | Composition | Stocks | Rural areas | Mapping | Management | Quinine | Institutions | Medicine | Technology | Cellular telephones | Weekly | Artemether | Visibility
Journal Article
The American journal of tropical medicine and hygiene, ISSN 0002-9637, 06/2015, Volume 92, Issue 6, pp. 8 - 16
The availability of falsified antimalarial drugs can be reduced with effective drug regulatory agencies and proper enforcement. Fundamental to these agencies...
SOLD | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | QUALITY | DRUGS | COUNTERFEIT ANTIMALARIAL TABLETS | ARTESUNATE | TROPICAL MEDICINE | Colorimetry - methods | Photometry - methods | Ethanolamines - standards | Tablets | Fluorenes - standards | Colorimetry - economics | Fluorescence | Artemisinins - standards | Antimalarials - standards | Ethanolamines - chemistry | Fluorenes - chemistry | Photometry - economics | Lasers | Antimalarials - chemistry | Counterfeit Drugs - chemistry | Developing Countries | Artemisinins - chemistry | Drug Combinations | Laboratory Innovations
SOLD | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | QUALITY | DRUGS | COUNTERFEIT ANTIMALARIAL TABLETS | ARTESUNATE | TROPICAL MEDICINE | Colorimetry - methods | Photometry - methods | Ethanolamines - standards | Tablets | Fluorenes - standards | Colorimetry - economics | Fluorescence | Artemisinins - standards | Antimalarials - standards | Ethanolamines - chemistry | Fluorenes - chemistry | Photometry - economics | Lasers | Antimalarials - chemistry | Counterfeit Drugs - chemistry | Developing Countries | Artemisinins - chemistry | Drug Combinations | Laboratory Innovations
Journal Article